Aurora Spine Chairman of the Board David Rosenkrantz acquired the 1.25 million common shares of the company in a non-brokered private placement.
Here are four things to know:
1. Mr. Rosenkrantz now holds more than 5 million common shares, representing nearly 17.5 percent of the issued and outstanding common shares.
2. Prior to the offering, Mr. Rosenkrantz owned just over 4.1 million common shares, approximately 14 percent of the issued and outstanding common shares on a fully diluted basis.
3. Mr. Rosenkrantz's acquisition of the shares under the offering was indicated for investment purposes and there were no joint actors in connection with the purchase.
4. Proceeds of the offering, more than $150,000, will be used for general working capital purposes. Aurora Spine continues to focus on minimally invasive spine surgery technologies.